GO
Loading...

Carl Icahn

More

  • NEW YORK, Nov 4- Carl Icahn's publicly traded investment vehicle, Icahn Enterprises L.P., reported strong third-quarter results on Monday and the billionaire said now is the best time ever to be an activist investor. Shares of Icahn Enterprises, in which Icahn owns an 89 percent stake, jumped 6.5 percent on Monday to $108.78 and are up 145 percent in 2013..

  • Ariad adopts rights plan to protect tax assets Friday, 1 Nov 2013 | 10:54 AM ET

    Nov 1- Ariad Pharmaceuticals Inc adopted a shareholder rights plan to protect its tax credits, a day after sales of its flagship drug Iclusig were suspended due to safety concerns following an investigation by the U.S. health regulator.

  • *Ariad says working with FDA to find a way to bring drug back. WASHINGTON, Oct 31- Ariad Pharmaceuticals Inc has suspended sales of its leukemia drug Iclusig after an investigation by the U.S. Food and Drug Administration found that a significant number of patients developed life-threatening blood clots or narrowing of the veins.

  • Bill Ackman to unveil new Herbalife information: Source Thursday, 31 Oct 2013 | 12:14 PM ET
    Bill Ackman

    Bill Ackman is preparing another major presentation on Herbalife, a source says.

  • NEW YORK, Oct 31- Bill Gross, manager of the world's largest bond fund, urged fellow members of the "privileged 1 percent," earning the highest incomes, to support higher U.S. taxes on carried interest and capital gains to help the economy.

  • Blue Harbour's best bets     Thursday, 31 Oct 2013 | 8:36 AM ET

    Cliff Robbins, Blue Harbour Group, shares his top stock picks, including Akamai and Chico's FAS.

  • Meet the 'friendly activists'     Thursday, 31 Oct 2013 | 8:05 AM ET

    Most companies are intrigued when we first approach them about unlocking value, says Cliff Robbins, Blue Harbour Group, discussing how he approaches companies as an activist shareholder. And Peter Weinberg, Perella Weinberg Partners, weighs in.

  • Apple had a good quarter, not great: Pro     Tuesday, 29 Oct 2013 | 12:19 PM ET

    Famed investors like Carl Icahn and Bill Miller consider Apple a "no-brainer." Toni Sacconaghi, Bernstein Research senior analyst, explains why Apple did not have a great quarter.

  • Dell seals $24.9 bln buyout, delisting Tuesday Tuesday, 29 Oct 2013 | 11:44 AM ET

    SAN FRANCISCO, Oct 29- Dell Inc will delist from the Nasdaq at the close of Tuesday's trading, as founder Michael Dell and private equity house Silver Lake complete their controversial $24.9 billion buyout of the struggling PC maker.

  • Apple could hit $600 in 2014: Pro     Tuesday, 29 Oct 2013 | 11:03 AM ET

    Arik Hesseldahl, All Things Digital, and Amit Daryanani, RBC Capital Markets, discuss the bull and bear case for Apple.

  • Should Cook placate Icahn?     Tuesday, 29 Oct 2013 | 10:52 AM ET

    Rosabeth Kanter, Harvard Business School, and Jeffrey Sonnenfeld, Yale School of Management, discuss whether talk of Carl Icahn's activism is relevant to the future of the tech giant. "Cook is doing an exemplary job," adds Kanter, sharing her thoughts on Apple's CEO.

  • Trading Apple by the numbers: Pro     Tuesday, 29 Oct 2013 | 8:07 AM ET

    Walter Piecyk, BTIG analyst, provides his thoughts on Apple's outlook and what it has to do to gain market share.

  • Analyst places $625 target on Apple     Tuesday, 29 Oct 2013 | 7:12 AM ET

    Chris Caso, Susquehanna Financial Group analyst has the play on Apples fourth quarter earnings beat despite lower guidance growth.

  • Apple is ready for liftoff: Pro     Tuesday, 29 Oct 2013 | 6:11 AM ET

    This is our favorite stock, says Brian White, Cantor Fitzgerald, providing his outlook on the tech giant's growth rate amid growing competition.

  • Apple's margin outlook disappoints Monday, 28 Oct 2013 | 4:31 PM ET
    The Apple iPad Mini, left, and iPad Air are displayed in October at the Yerba Buena Center in San Francisco.

    Apple profit and margins slid despite selling a solid 33.8 million iPhones in its September quarter.

  • Oct 28- Apple Inc's iPhone sales and revenue forecasts, due to be released on Monday, may offer clues as to whether its low-cost 5 C model missed the mark or whether the world's largest tech company can continue its run of smash-hit gadgets. Apple will be reporting results just a week after taking the wraps off an incrementally improved iPad Air.

  • Slicing Apple's fourth quarter     Monday, 28 Oct 2013 | 8:33 AM ET

    Daniel Ernst, Hudson Square Research, provides a look at what he is expecting to see from the tech giant's quarterly results.

  • Apple's iPhone sales, holiday quarter up for scrutiny Sunday, 27 Oct 2013 | 11:00 PM ET

    Oct 27- Apple Inc's iPhone sales and revenue forecasts, due to be released on Monday, may offer clues as to whether its low-cost 5 C model missed the mark or whether the world's largest tech company can continue its run of smash-hit gadgets. Apple will be reporting results just a week after taking the wraps off an incrementally improved iPad Air.

  • Inside Icahn Enterprises     Friday, 25 Oct 2013 | 3:45 PM ET

    Activist investor Carl Icahn netted huge profits on his Netflix sale this week as well as increasing his position and presence in Apple. CNBC's Mary Thompson takes a look inside Icahn Enterprises.

  • As risk in corporates rises, banks are new safe play Friday, 25 Oct 2013 | 12:51 PM ET

    Carl Icahn, having seen David Einhorn's agitation result in Apple issuing a US $17 bn bond in April to pay for part of a US $100 bn shareholder capital return program, said he had increased his stake in the company- and repeated calls for the tech giant to make an additional US $150 bn worth of share buybacks.

Most Popular Video

Thursday, 17 Apr 2014 | 5:00 AM ET

Today is CNBC's 25th anniversary. There have been a lot of great moments in the network's history. Here are just a few.

Thursday, 17 Apr 2014 | 3:15 AM ET

Jonny Forsyth, global drinks analyst at Mintel, says China has been a "cash cow" for drink-makers, but the slowdown is having a big impact on sales.

Thursday, 17 Apr 2014 | 1:35 AM ET

CNBC's Helia Ebrahimi discusses the Co-Operative's troubled story from drug buying allegations against the former chairman, to big financial black holes.